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Abstract 
Neurocognitive dysfunction is the leading cause of reduced quality of life in the long-term 
survivors of paediatric brain tumours. Radiotherapy is one of the significant contributors to 
neuro-cognitive sequelae. The current approaches in prevention and/or reduction in 
neurocognitive dysfunction include avoidance of radiotherapy in young children and 
reduction of radiotherapy dose and volume of brain irradiated. There have been considerable 
advances in brain imaging, especially with functional imaging and fibre tracking using 
diffusion tensor imaging. Radiotherapy techniques for photon therapy have also evolved in 
recent years with the wide-spread use of techniques such as image-guided radiotherapy 
(IGRT), volumetric modulated arc therapy (VMAT), helical tomotherapy, and adaptive 
radiotherapy (ART).  The number of proton beam therapy facilities is increasing globally and 
there is a great enthusiasm for the clinical use of newly developing MRI-guided radiotherapy 
systems. We review the potential role of modern imaging and innovative radiotherapy 
techniques in minimising neurocognitive sequelae in children with brain tumours and various 
strategies to integrate these advances to drive further research. 
 
 
Search strategy and selection criteria 
References for this review were identified through searches of PubMed with the search terms 
"brain tumours", "radiotherapy”, “imaging”, “functional mapping”, “diffuse tensor imaging”, 
“fibre tracking”, “intensity-modulated”, “proton beam”, “MRI-Linac”, “IGRT”, “VMAT”, 
“Tomotherapy” from 1990 to June 2016. Only papers published in English were reviewed. 
The final reference list was generated on the basis of originality and relevance to the broad 
scope of this review. 
  
Introduction 
Brain tumours, the most common solid tumours in children, constitute more than 20% of 
paediatric cancers (1, 2). With the current advances in treatment, more than 70% of children 
are long-term survivors (3). Almost a half of paediatric patients will develop progressive 
neurological deficits (4). This is reflected in lack of attainment of academic and professional 
potential (5). 
The development of neurocognitive dysfunction is contributed to by a number of disease-, 
treatment- and host-related factors such as location and size of the tumour, age at diagnosis, 
surgery, radiotherapy, chemotherapy, and premorbid intellectual and neurological function 
(6). Studies also suggest that genetic effects may influence various elements of cognitive 
function (7).  
Radiotherapy is one of the major contributing factors to neuro-cognitive dysfunction, which 
is typically progressive in nature (5, 8). Cognitive dysfunction can affect four main domains: 
global cognitive functioning (IQ), academic achievements, executive function, and 
psychomotor skills (6, 9). Prevention or minimization of radiation-induced cognitive 
dysfunction has been a topic of intense research for a long time. The only measures which 
have achieved some success to date are avoidance of radiotherapy in young children, 
especially less than three years of age and reduction in the total radiation dose and volume of 
brain irradiated (10, 11).  
Recently, there have been considerable advances in brain imaging, particularly with 
functional mapping and fibre tracking using diffusion tensor imaging (12). Some of these 
advances are being exploited in the surgical management of brain tumours and radiosurgery 
(13-16). However, integration of these technologies to improve radiotherapy planning is 
slow. In this article, we review the role of modern imaging in understanding neurocognitive 
dysfunction, discuss the potential role for imaging and innovative radiotherapy techniques in 
minimising neurocognitive sequelae, and derive inspirational strategies to integrate these 
advances to drive further research. 
 
Mechanisms of radiation-induced neurocognitive dysfunction 
Radiotherapy can damage progenitor cells, inflammatory and stromal cells, and vasculature 
(17). Radiotherapy induced inflammation, angiogenesis and cell death can lead to white and 
grey matter damage (9). Both white and grey matter development depends on the age of the 
individual and full myelination of the cerebral cortex is achieved only in early adulthood. In 
adults, neurocognitive dysfunctions are irreversible and progressive, affecting particularly the 
domains of processing speed and memory and in severe cases leading to ataxia, urinary 
incontinence, and dementia in 2-5% (18, 19). In children, radiotherapy can prevent age-
appropriate normal maturation and myelination of brain and/or damage to white matter tracts 
(20). The molecular effects of radiotherapy-induced cognitive dysfunction have been 
reviewed recently (21).  
Impact of radiotherapy parameters 
The risk and severity of neurocognitive dysfunction depends on a number of patient-and 
disease-related factors and radiotherapy parameters. Studies show that the risk of 
neurocognitive dysfunction increases with increasing dose of radiotherapy, with a progressive 
deterioration over time (22, 23). Radiotherapy prevents children acquiring new skills and 
knowledge, leading to progressive worsening of deficit over time (5). In a meta-analysis, 
cranial radiotherapy, chemotherapy and longer time since diagnosis were associated with 
lower general intelligence (24). Children with infratentorial tumours and younger age have a 
higher risk of neurocognitive dysfunction (8, 25).  Children under 3 years are particularly 
vulnerable to deleterious effects of radiotherapy due to rapid cell proliferation and 
myelination and dendritic and axonal outgrowth and radiotherapy is generally avoided in this 
age group (10, 24).  
 
Eloquent brain areas and domains in neuro-cognition 
A number of areas are important in neuro-cognition, but the relative contribution of 
individual areas in overall cognition is still to be fully understood. Neurons and glial cell are 
produced from the neurogenic stem cells located in the subventricular zone of the lateral 
ventricles and subgranular zone of the hippocampal gyrus (26).  These areas are part of the 
limbic system and continuous renewal of neurons from the stem cells is important in memory 
(27). The limbic system consists of hippocampus, parahippocampal gyrus, and amygdaloid. 
These structures located in the temporal lobe are important in various aspects of memory and 
emotional learning. In a study of 32 children treated with proton therapy, even though 
neurocognitive function is relatively spared, children less than 7 years and those who 
received a higher dose to the left temporal lobe or hippocampus had worse neuro-cognitive 
dysfunction (28).  
The frontal pole, anterior cingulate and frontal white matter horn are important in working 
memory and executive function, whereas the corpus callosum is involved in cognition and 
processing speed (29, 30). The stem cells within the subventricular zone (SVZ) are important 
in injury repair and thereby maintain the ability for life-time learning (31, 32). The 
hippocampus which forms part of the limbic system is involved in the consolidation of new 
memory (33-35). While the impact of radiation to these areas is not correlated with 
neurocognitive dysfunction in prospective studies, a number of studies in adults with brain 
metastases have shown that with sparing of the hippocampi, the incidence of neuro-cognitive 
sequelae can be significantly reduced (36). However, the role of hippocampal sparing to 
preserve cognitive function in children is yet to be studied and it is not certain that a simple 
sparing of the hippocampus, which measures approximately 1% of total brain volume, would 
be sufficient to prevent neurocognitive dysfunction in children (32). It is also unknown 
whether sparing of a unilateral hippocampus has an impact on preservation of cognition. 
Studies of metastatic brain tumours in adults suggest that the risk of recurrence in the 
hippocampal region is low and therefore hippocampal sparing is a feasible option without 
compromising local control of disease (37, 38). However, neither the true incidence of 
hippocampal spread nor the risk of disease recurrence in the hippocampal region in paediatric 
brain tumours is known.  
The neurons from the cerebellum form a series of closed loops with neurons in the prefrontal 
cortex, temporal lobes and limbic structures. Damage to these neurons could lead to the 
postoperative sequelae of posterior fossa syndrome (cerebellar mutism) in medulloblastoma 
and also to late neurocognitive dysfunction (39, 40). 
 
Conventional imaging in neurocognitive dysfunction  
Conventional anatomical MRI changes include white matter changes, mild enhancement, and 
oedema in the distribution of the radiation field (17). Diffuse white matter changes (often 
referred to as leucoencephalopathy) develop in 16% of children treated with radiotherapy for 
malignant brain tumours after a median interval of 7.8 months (41). These lesions were most 
commonly seen in the pons and cerebellum and 73% of lesions fully resolved after a median 
interval of 6.2 months (41). In children with acute lymphoblastic leukaemia (ALL) who were 
only treated with chemotherapy, white matter changes were found in 10% at the end of 
treatment and in 12% of patients at 5 years (42). Although a minority of patient with these 
white matter lesions develop permanent neurological deficits, the development of these 
lesions appears to be a poor predictor of neurocognitive deficits (41-43). 
It is recognised that volumetric measurement of the brain can identify global atrophy and that 
chemoradiotherapy in adults with brain tumours results in loss of brain volume (44). Studies 
correlating global brain volume changes have failed to show any association in adult 
survivors of paediatric brain tumours (45).  
It is clear that conventional MR methods are not sensitive enough to identify changes that 
predict neurocognitive dysfunction. The development of new imaging methods sensitive to 
pathological alteration will allow better understanding of these changes. 
 
Importance of white matter structures on neurocognitive decline 
Studies that measure changes in white matter volume have shown that decrease in white 
matter volume following radiotherapy correlates with IQ decline and neurocognitive decline 
(46-49). Voxel based morphometry approaches show that frontal white matter (especially 
right sided) is more sensitive to volume loss than other parts of the brain (48). Increased 
white matter volume loss is associated with intensity of CNS treatment (i.e. treatment for 
brain tumours has a greater effect than craniospinal irradiation for ALL), younger age of 
treatment and the interval between treatment and imaging study (50).  
 
 
Advanced MRI techniques for brain imaging  
Functional MRI using BOLD imaging 
Functional MRI (fMRI) is a well-established technique to identify cortical areas that are 
activated undertaking a specific task. During cortical activation there is a transient, focal 
increase in blood flow that can be measured by differences in the magnetic properties of 
haemaglobin depending on its oxygenation status. Deoxyhaemaglobin is paramagnetic and as 
a result shortens the T2* of the blood and its surroundings. Oxyhaemaglobin is diamagnetic, 
and as a result increasing oxygenation of blood reduces the T2* shortening and increases the 
T2* signal. This ‘blood-oxygen-level dependent’ (BOLD) contrast can be detected using 
heavily T2*-weighted sequences such as gradient-recalled echo (GRE) and echo planar 
imaging (EPI). The transient increase in T2* signal during activation is small and detected by 
statistical analysis. BOLD signal intensity is reduced with increasing age, increasing tumour 
grade, proximity to tumour, and previous surgery (51-55). The accuracy of the BOLD 
imaging in detecting areas of activation has been assessed in adults undergoing awake 
surgery with cortical stimulation. There appears to be very good accuracy of fMRI correctly 
identifying regions of motor activation as compared to the gold standard of direct cortical 
stimulation (sensitivity of 87% and specificity of 88%) (56). This accuracy decreases with 
increasing tumour grade (56). Overall the discrepancy between fMRI and cortical areas 
stimulated were only 6 – 13.8 mm (57). All studies suggest 96-100% of fMRI activated areas 
were within 2 cm of cortical stimulation: the difference may be due to registration errors (57). 
There is reasonable repeatability of motor function. 
Language function, however, is not so well localized by BOLD imaging. Studies correlating 
fMRI activation with cortical stimulation show that sensitivity and specificity are worse than 
motor (80% and 78% respectively) (56). As BOLD signal can be affected by proximity to the 
tumour, even lateralising language function can be affected by the reduced volume of BOLD 
effect if it is near the tumour and so can be misleading (58). It is clear that use of multiple 
language tasks improves accuracy. The sensitivity of naming or verb generation on their own 
is 22% and 36% respectively. This improves to 59% if these tasks are combined (59). The 
repeatability of detecting language function is very poor – for individual tasks the overlap is 
9-26%. This improves to 39-44% if they are combined (60). Test-retest accuracy was worse 
in high-grade tumours compared to low-grade (61).  
Resting State fMRI 
The fMRI methods described above are all task based where changes in blood flow are 
measured during a task and compared to rest. This accounts for a fraction of the brain activity 
and it was realized that BOLD fluctuations can be identified at rest. By correlating these 
regions of BOLD activation it is possible to link regions and develop networks. The 
methodology and background to this technique of resting state fMRI has recently been 
reviewed (62). There is much interest among cognitive neuroscientists to use this to study 
brain networks and metrics of this network has been shown to correlate with cognitive 
reserve (63). This has not been used to assess impact of radiotherapy but is an exciting 
method for future research. 
Diffusion tensor imaging of white matter integrity  
Diffusion tensor imaging (DTI) helps to study the integrity of white matter structures. DTI, in 
which uses a magnetic resonance signal visualizes water movement within axons, has been 
used to study white matter development in children. Diffusion of water is high along, and low 
perpendicular to white matter tracts, resulting in an anisotropic diffusion profile. If you could 
plot the location of a water molecule diffusing through the brain it would be in the shape of 
an ellipse with the long axis describing the principal axis of diffusion. Tensor calculus can be 
used to provide quantification of this tensor.  The commonest method of quantifying 
anisotropy uses the fractional anisotropy (FA) value which lies between 0 (for isotropic 
diffusion, i.e. diffusion is equal in all directions) and 1 (maximum anisotropic diffusion, i.e. 
along one axis). The degree of anisotropy depends on white matter fibre diameter and 
density, the myelin sheath, other macromolecular structure that hinder proton diffusion and 
fibre-tract coherence (64). By linking adjacent ‘ellipses’ in different voxels using the 
principal axis it is possible to develop a probabilistic map of white matter tracts 
(tractography). DTI tractography is useful for characterising the major white matter pathways 
(65).  
Studies have shown that development in cognitive function in children and adolescents 
correlates with an increase of FA (66, 67). Studies looking at the effect of radiotherapy on 
white matter tract integrity have shown a reduction in FA in white matter of children treated 
with radiotherapy and this decrease in FA correlates with IQ, tests of neuropsychology 
function, and school performance (45, 49, 68-71). The decrease in FA is more noticeable with 
earlier age radiotherapy and increased radiotherapy dose (68, 70-73). The interval between 
radiotherapy and the DTI study provides differing results, with some studies suggesting it is 
correlated with reduced FA whilst others found no association (70, 71).  
What is clear is that some regions of the brain are more sensitive to radiotherapy than others. 
Studies have shown a greater decrease in FA in the frontal and temporal lobes (74-76). This 
reduction, especially in the frontal lobes, is greater despite similar doses of radiotherapy (68). 
Reduction in FA in frontal and parietal lobes is associated with neurocognitive decline (77). 
Other structures that are affected by radiotherapy include periventricular white matter, corpus 
callosum, anterior and posterior limbs of the internal capsule, the corona radiate, and fornix 
(69, 75, 78, 79). 
The difficulty with using DTI to study changes in white matter integrity from radiotherapy is 
that chemotherapy alone can lead to white matter disruption. Studies in patients treated with 
chemotherapy alone had reduced FA in white matter. Reduction in FA in the corpus callosum 
was associated with neurocognitive decline, and a reduction in FA in the inferior fronto-
occipital fasciculus was associated with a diminished motor processing speed (20). 
Comparing patient groups that received chemotherapy with radiotherapy showed a larger 
reduction in FA compared with patients treated with chemotherapy alone (70, 80).  
Another problem is that changes in FA do not appear to be diagnostic. There are other studies 
in children reporting a lower FA in several eloquent brain regions, but without any 
correlating specific neurocognitive dysfunction (69) (table 1). 
Advanced radiotherapy techniques 
There are no prospective studies evaluating the role of selecting sparing of various eloquent 
areas and domains of brain associated with different elements of cognitive function. A 
retrospective, which has evaluated radiotherapy dose to potential functional targets of 
cognitive function, has shown that radiotherapy to the corpus callosum, left frontal white 
matter, right temporal lobe, bilateral hippocampi, subventricular zone and cerebellum 
affected global cognitive outcome at doses <60 Gy (32).  
While, the dose threshold of these different structures for cognitive decline is unknown, the 
modern radiotherapy technology can effectively spare or minimise radiotherapy to any brain 
structures. For example, advanced intensity-modulated radiotherapy (IMRT) methods such as 
volumetric modulated arc therapy (VMAT) and helical tomotherapy are used effectively to 
spare hippocampi in brain tumours (36, 81-83). 
The physical advantage of proton therapy in terms of a significant reduction in radiotherapy 
dose to normal tissues outside the tumour volume could be exploited to reduce the 
neurocognitive dysfunction following radiotherapy (84). In a study of children with low-
grade glioma treated with proton therapy (n=32), 12 had neurocognitive assessment, which 
did not show any significant declines in Full-Scale Intelligence quotient (FSIQ) at a median 
of 4.5 years (28). However, dose to the left temporal lobe/hippocampus was associated with 
decline in cognitive function. In a recent phase II study of proton therapy for 
medulloblastoma, there was a decline in FSIQ of 1.5 points per year (95% CI 0.9-2.1) 
primary due to a decline in processing speed and verbal comprehension (85). However, 
perception reasoning and working memory were not affected at a median follow-up of 5.2 
years. FSIQ declined significantly in children <8 years.  
While the initial reports of modern radiotherapy techniques and proton therapy are 
encouraging, none of the studies correlated the radiotherapy dose to different eloquent areas 
or domains with neurocognitive function.  
 
The potential for integrating modern imaging with novel radiotherapy technique 
Strategies to prevent or minimise radiation-induced neurocognitive dysfunction include 
avoidance of radiotherapy in children less than 3 years, optimal integration with 
chemotherapy to minimise the total dose of radiotherapy and/or volume of brain treated, 
optimal target delineation using better imaging, and use of highly conformal radiotherapy 
techniques.  
Modern radiotherapy planning is based on a conventional MRI scan co-registered with a 
planning CT scan. The clinical benefit of integration of functional imaging and tractography 
for fractionated radiotherapy planning in brain tumour has not been studied. However, a 
number of studies have evaluated the role of functional imaging for radiosurgery treatment 
planning for benign brain conditions, particularly arteriovenous malformations (AVMs) (15, 
16, 86, 87).  The frequency of motor complications after corticospinal tractography-
integrated-radiosurgery for patients with AVMs involving the basal ganglia and thalamus 
(n=24) were significantly less compared with a historical cohort (n=28) without tractography 
integration (4.2% vs. 17.9% p=0.021) (88).  There was no significant difference in 4-year 
AVM obliteration rate (69% vs. 76%, p=0.68). In another study of 71 patients undergoing 
tractography integrated radiosurgery for AVMs (45 pyramidal tract, 22 optic radiation, and 
13 arcuate fasciculus) with a median follow-up of 23 months, only one patient had new 
persistent morbidity from worsening of pre-existing dysaesthesia (15).  Tractography is 
increasingly being integrated into radiosurgery planning for benign brain conditions (Figure 
1).  
In a feasibility study of 4 patients with low-grade glioma, Kovacs et al co-registered fMRI 
following acoustic, visual, somatosensory and numeral stimuli to a planning CT scan (89). 
The study showed that with fMRI based 3D conformal planning, radiotherapy dose to the 
superior and inferior temporal gyrus and lingual gyrus could be reduced by an average of 
50%. A subsequent study of 10 patients with brain tumours confirmed the role of fMRI in 
reducing dose to critical organs without compromising tumour target coverage (90).  
A planning study has shown that integrating diffusion tensor tractography into IMRT 
planning has significantly reduced radiotherapy dose to the corticospinal tract in patients with 
glioblastoma (91). In another study of 20 patients with high-grade glioma, bilateral motor 
cortex and corticospinal tracts were marked using integrated DTI and BOLD-fMRI as organs 
at risk (OARs), which led to a reduction in the dose of radiotherapy using IMRT (92). Thus 
studies have shown that both DTI and BOLD-fMRI can be integrated into planning CT/MRI 
scan to delineate critical nerve tracks and eloquent regions for functional avoidance 
radiotherapy (figure 2).  
 
Challenges of integration of functional imaging for radiotherapy planning 
There are no long-term longitudinal studies correlating radiotherapy tolerance of various 
brain domains with neurocognitive dysfunction. One of the pre-requisites for use of 
functional avoidance radiotherapy is the robust understanding of the patterns of spread of 
individual brain tumours and the potential risk of relapse in an eloquent track or part of the 
brain. This necessitates carefully planned patterns of relapse studies which should be 
correlated with individual functional MRI scans.  
While planning of radiotherapy using fMRI seems to be feasible, it is not certain whether the 
treatment can be delivered daily with high accuracy. Adaptive radiotherapy techniques using 
image guidance are evolving for a number of cancers. However, this technology has not been 
fully evaluated in brain tumours. While routine radiotherapy planning involves co-
registrations of MRI scan with CT scan, the usual treatment verification is mainly based on 
bony anatomy. A robust method of delivery of functional avoidance radiotherapy using fMRI 
needs treatment verification with an MRI scan. MRI-LINAC is a new advance which 
integrates a verification MRI scan with the radiotherapy treatment machine to deliver MRI-
guided adaptive radiotherapy (93). This technology could be exploited further to deliver MRI 
guided, functional avoidance radiotherapy for paediatric brain tumours in the future.  
 
Future directions 
Radiotherapy techniques are now able to avoid potential areas of neurocognitive function 
when combined with optimal imaging. This needs to be assessed prospectively with 
neurocognitive function and tumour control as the primary outcomes.    However, without 
proper knowledge of patterns of failure of different brain tumours, it would be unsafe to 
avoid radiotherapy to areas of brain which may harbour tumour.  
With prospective studies we would be able to identify eloquent areas and tracts important in 
cognition and to correlate the effect of dose and volume of radiotherapy on specific cognitive 
domains. These studies would pave the way to functional image-guided risk-adapted 
radiotherapy for children with brain tumours.  
While the concept of integration of functional imaging and tractography with modern 
radiotherapy to identify knowledge gaps in the correlation of radiotherapy parameters and 
neuro-cognitive function appears to be attractive in principle, there are a number of logistic 
challenges which can be addressed only with a prospective multi-stage collaborative 
approach (figure 3). Unfortunately, this approach will not yield a quick result, which can be 
integrated into the routine clinical practice. Nevertheless, clinicians should not be 
discouraged to embark on a path of slow and steady but incremental progress towards 
developing functional-image guided avoidance radiotherapy in children with brain tumour to 
maintain the highest quality of life without compromising the chances of cure.  
 
Table 1 Studies on the role of DTI in assessing neurocognitive dysfunction in children with brain tumours 
Study No of patients DTI finding  Summary of conclusion  
Malbott et al 2006(69) 8 medulloblastoma patients 
and controls 
Reduced IQ is associated with increased ADC 
and reduced FA. Corpus callosum and anterior 
and posterior limb of internal capsule has most 
reduced FA. 
Reduced FA and increasesd ADC seen mostly in 
anatomical regions and correlates with reduced 
IQ. 
Khong et al 2006(68) 9 medulloblastoma patients 
(treated with RT and chemo) 
vs controls. 
Reduced FA in all regions – even where 
conventional imaging normal. Greater decrease 
in FA correlated with earlier age of treatment, 
longer interval from treatment and reduced 
school performance 
Treatment related reduced FA. Correlates with 
school outcomes. Age of treatment important 
factor. 
Qiu et al 2007 (74) 22 medulloblastoma survivors 
and controls 
Calculated difference of FA and calculated 
dose. Decreased FA has dose response. 
Reduced FA frontal WM more than parietal 
WM despite similar RT dose. 
Reduced FA has dose and anatomical location 
relationship. 
Aukema et al 2009(20) 17 patients treated for 
medulloblastoma or ALL all 
treated with chemotherapy 
Reduced FA compared to controls. Correlates 
with neurocognitive decline from splenium and 
body of corpus callosum. Correlates with motor 
processing with inferior fronto-occipital 
fasciculus. 
Reduced FA in treated patients. Regional 
variation leads to differences in functional 
deficit. 
Rueckriegel et al 
2010(75) 
13 patients with pilocytic 
astrocytomas (not treated with 
RT) and 17 medulloblastomas 
(treated with RT) 
Decreased FA in medulloblastoma in midline 
cerebellar structures, frontal white matter and 
body of CC – the latter two not seen in 
pilocytic astrocytoma. 
Difference between group was RT. Significant 
difference in FA. No correlation with outcome. 
Brinkman et al 2012(45) 20 patients with 
medulloblastoma 
RAD (radial diffusivity) in the frontal lobes 
was negatively correlated with shifting 
attention and cognitive flexibility and FA in 
parietal lobe was positively correlated with 
working memory and  
Reduced white matter integrity in multiple brain 
regions correlated with deterioration in executive 
function 
Palmer et al 2012(94) 40 patients with 
medulloblastoma treated with 
Patients had significantly lower FA throughout 
WM fibre tract compared to controls. Lower 
Commissural fibes in the corpus callosum are 
negatively affected by disease and treatment 
surgery and radiotherapy 
compared with healthy 
controls 
FA within genu, body and splenium of the 
corpus callosum is associated with lower 
processing speed 
which leads to detrimental effects in cognitive 
processing.  
Horska 2014(95) 8 brain tumours and 1 ALL, 9 
normal developing children as 
control  
Patients had 24% higher overall mean ADC in 
the hippocampus compared with control  
Difference in tissue sensitivity to injury among 
gray matter regions may exist.  
King 2015(96) 27 patients (14 had 
radiotherapy) compared with 
27 healthy volunteers 
Lower FA in the white matter of the anterior 
portion of corpus callosum, right middle 
temporal and frontal regions in the radiotherapy 
group and it correlated with intellectual 
performance 
Lower white matter integrity leaders to lower 
intellectual outcome. Radiotherapy and 
chemotherapy may contribute to white matter 
disruption  
    
Rueckriegel 2015(49) 18 medulloblastomas vs. 15 
pilocytic astrocytomas.  
Changes in volume of WM: GM+CSF and 
reduction of FA correlate with cognitive 
function, IQ, processing speed and shifting 
speed. 
Changes in FA and white matter volume loss 
correlates with neuropsychology outcomes. 
 
Figure 1 Examples of integration of tractography with radiosurgery for benign brain 
conditions: (A) trigeminal neuralgia and (B) thalamotomy for tremor (Courtesy of Prof T 
Kaprealian, UCLA Department of Radiation Oncology, Los Angeles, USA) 
 
  
Figure 2  Functional BOLD MRI and tractography can be combined with anatomical MRI 
scan for treatment planning: (A) BOLD image after functional activation, (B&C) position of 
tract in relation to tumour and the brainstem and (D) volumetric representation of tumour 
(pink), activation areas (green), and tracts (yellow) superimposed on the brain surface 
(reproduced with permission from BRAINLAB) 
 
  
Figure 3 Schematic proposal for a multi-stage approach to develop functional avoiding 
mapping image-guided radiotherapy for paediatric brain tumour 
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